(UKS35837) Has the MHRA any plans to meet with other activists & victims of drugs such as Cipramil, Prozac, Lustral & Efexor etc

http://groups.yahoo.com/group/uksurvivors/message/35837


From: Jeremy Bryce [mailto:jeremybryce1953@...]
Sent: 11 April 2008 15:55
To: Watkins, John
Subject: Meeting Janice Simmons & others re antidepressants


John.Watkins@mhra.gsi.gov.UK


John Watkins
Communications Manager,
Medicines and Healthcare products Regulatory Agency (MHRA)







Dear Mr Watkins


I refer you to http://fiddaman.blogspot.com/

Post Friday, April 11, 2008

Headed -MHRA - A small light at the end of this very long dark tunnel

& in particular to text


" We would like to take stock of your request for a meeting in the light of the outcome of the meeting with Janice and those she may bring with her. Indeed you might see that meeting as fulfilling the suggestion in your email that the MHRA and anti-Seroxat/SSRI campaigners should get together to discuss the issues. "







This in my opinion is highly questionable especially

(a) since the members of the Seroxat lobby stand to materially gain by any intervention that the MHRA might ultimately have to take against GSK

(b) the MHRA appears to be offering preferential regulating services to consumers of one brand of SSRI, whilst leaving the field open for obvious substandard supervision & hence public danger, to consumers of other SSRI's & SNRI's such as Efexor.

For example

I would draw your attention to the homicidality issue with Efexor & my earlier question I raised with Miss Shahin Kauser
Ref 21 December 2005 MHRA Reference: LQ05/3453.

Her answer is highly ambiguous at best.

See

http://www.theeffexoractivist.org/forum/viewtopic.php?t=471







My question then John

Has the MHRA any plans to meet with other activists & victims of drugs such as Cipramil, Prozac, Lustral & Efexor to name but four but exclude none other ?


Or

Would the MHRA decline such a request and prefer to deal with this letter as previously intimated by me, to you personally, as a complaint of (Regulatory) partiality against users/former users of SSRI/SNRI other than Seroxat ?

Regards

Jeremy Bryce
*** **** ****
***********
*********
*************

See also

[PDF]
1 Effexor XR (venlafaxine hydrochloride) Extended-Release Capsules ...
File Format: PDF/Adobe Acrobat - View as HTML
Or suicidal ideation. The efficacy of Effexor (immediate release) in the ...... Facial paralysis, abnormal gait, Guillain-Barre Syndrome, homicidal ...
www.wyeth.com/content/ShowLabeling.asp?id=100 -








This email was received from the INTERNET and scanned by the Government Secure Intranet anti-virus service supplied by Cable&Wireless in partnership with MessageLabs. (CCTM Certificate Number 2007/11/0032.) In case of problems, please call your organisation's IT Helpdesk.
Communications via the GSi may be automatically logged, monitored and/or recorded for legal purposes.

This email and any files transmitted with it are confidential. If you are not the intended recipient, any reading, printing, storage, disclosure, copying or any other action taken in respect of this email is prohibited and may be unlawful.




If you are not the intended recipient, please notify the sender immediately by using the reply function and then permanently delete what you have received.Incoming and outgoing email messages are routinely monitored for compliance with the Department of Healths policy on the use of electronic communications.




For more information on the Department of Healths email policy, click

http://www.dh.gov.uk/DHTermsAndConditions/fs/en?CONTENT_ID=4110945&chk=x1C3Zw


The original of this email was scanned for viruses by the Government Secure Intranet virus scanning service supplied by Cable&Wireless in partnership with MessageLabs. (CCTM Certificate Number 2007/11/0032.) On leaving the GSi this email was certified virus free.
Communications via the GSi may be automatically logged, monitored and/or recorded for legal purposes.